Aug. 28, 2026 — Royal Philips and Imricor Medical Systems have announced a new Interventional MR (iMR) lab solution for Philips 1.5T MR. The first commercially available configuration* combines ...
Interventional Cardiology
Aug. 28, 2026 — Royal Philips and Imricor Medical Systems have announced a new Interventional MR (iMR) lab solution for ...
Aug. 26, 2026 – The Cardiovascular Research Foundation (CRF) announced the late-breaking clinical trials and science sel ...
Aug. 20, 2026 — Bayer has announced that 11 oral presentations across its cardiovascular, kidney, and secondary stroke ...
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
Aug. 4, 2026 — Abbott has completed enrollment in its TECTONIC coronary artery disease (CAD) Intravascular Lithotripsy ...
July 9, 2026 — On July 9, Stereotaxis announced that it has completed its previously announced acquisition of Robocath ...
June 17, 2026 — VahatiCor, Inc., a medtech company developing interventional therapies for coronary microvascular ...
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
June 15, 2006 — Penumbra, Inc. has secured the CE Mark in Europe for Thunderbolt, further laying the groundwork for ...
June 11, 2026— Penumbra, Inc. has received U.S. Food and Drug Administration (FDA) clearance for Thunderbolt, expanding ...
May 11, 2026 — In May, Robocath announced the completion of patient enrollment in the FIH (First-In-Human) clinical ...
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
May 13, 2026 — According to a recently released report, the global cath lab services market was valued at $46.0 billion ...
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
September 01, 2026